Imdusiran data from IM-PROVE I and IM-PROVE II Phase 2a clinical trials to be presented at upcoming AASLD - The Liver Meeting ...

Third quarter revenues of $50.7 million, in line with previous guidanceThird quarter GAAP net loss of $0.9 million; non-GAAP net income of $5.5 ...

In his many visits to the Badger State, Trump campaigned hard on the economy, which polls consistently found to be the most important issue to voters there. Wisconsin has the second-highest ...